Drug data last refreshed 9h ago · AI intelligence enriched 3w ago
NEO-CORT-DOME is a topical cream combining hydrocortisone (corticosteroid) and neomycin sulfate (antibiotic) for treating inflammatory and infected dermatological conditions. The hydrocortisone reduces inflammation and itching while neomycin targets bacterial infections, making it a combination therapy for conditions like eczema with secondary infection or infected dermatitis.
As an aging NDA approaching loss of exclusivity with moderate competitive pressure (30%), this product likely operates with a smaller, maintenance-focused team focused on defending market share.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on NEO-CORT-DOME offers limited growth trajectory but provides stable experience in mature product management, generic defense strategies, and dermatology market expertise. This role suits professionals seeking tactical execution experience or transitional positions before moving to growth-stage products.
Worked on NEO-CORT-DOME at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.